TY  - GEN
AU  - Hsieh,Yi-Chung
AU  - Jeng,Wen-Juei
AU  - Huang,Chien-Hao
AU  - Teng,Wei
AU  - Chen,Wei-Ting
AU  - Chen,Yi-Cheng
AU  - Lin,Shi-Ming
AU  - Tai,Dar-In
AU  - Lin,Chun-Yen
AU  - Sheen,I-Shyan
TI  - Hepatic decompensation during paritaprevir/ritonavir/ombitasvir/dasabuvir treatment for genotype 1b chronic hepatitis C patients with advanced fibrosis and compensated cirrhosis
SN  - 1932-6203
PY  - 2019///0208
KW  - 2-Naphthylamine
KW  - Aged
KW  - Aged, 80 and over
KW  - Anilides
KW  - administration & dosage
KW  - Antiviral Agents
KW  - Carbamates
KW  - Cohort Studies
KW  - Cyclopropanes
KW  - Drug Therapy, Combination
KW  - Female
KW  - Genotype
KW  - Hepacivirus
KW  - genetics
KW  - Hepatitis C, Chronic
KW  - drug therapy
KW  - Humans
KW  - Hyperbilirubinemia
KW  - chemically induced
KW  - Lactams, Macrocyclic
KW  - Liver Cirrhosis
KW  - Macrocyclic Compounds
KW  - Male
KW  - Middle Aged
KW  - Proline
KW  - analogs & derivatives
KW  - Prospective Studies
KW  - Risk Factors
KW  - Ritonavir
KW  - Sulfonamides
KW  - Sustained Virologic Response
KW  - Treatment Outcome
KW  - Uracil
KW  - Valine
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1371/journal.pone.0202777
ER  -